TD Securities (USA)’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$24K Hold
89
0.22% 43
2015
Q4
$28K Sell
89
-136
-60% -$40.5K 0.25% 34
2015
Q3
$61K Sell
225
-158,713
-100% -$48.8M 0.56% 37
2015
Q2
$48.2M Buy
158,938
+18,662
+13% +$5.57M 0.65% 32
2015
Q1
$41.7M Buy
140,276
+39,623
+39% +$11.3M 0.63% 34
2014
Q4
$25.9M Buy
100,653
+8,217
+9% +$2.05M 0.37% 61
2014
Q3
$22.3M Sell
92,436
-51
-0.1% -$11.4K 0.36% 63
2014
Q2
$20.6M Buy
92,487
+35,322
+62% +$7.31M 0.33% 76
2014
Q1
$11.8M Sell
57,165
-4,241
-7% -$840K 0.21% 117
2013
Q4
$10.3M Buy
61,406
+15,814
+35% +$2.47M 0.17% 140
2013
Q3
$6.57M Buy
45,592
+2,034
+5% +$271K 0.13% 194
2013
Q2
$5.5M Buy
+43,558
New +$4.93M 0.11% 221

Other funds holding AGN

TD Securities (USA)'s AGN Position: Q1 2016 in Review

TD Securities (USA) held its Allergan plc (AGN) position steady in Q1 2016 at 89 shares worth $24K. The position accounts for 0.22% of the portfolio, ranked #43.

TD Securities (USA) first reported a position in AGN in Q2 2013 and has held it in 12 quarters since. The position peaked at $48.2M in Q2 2015. 1,119 funds tracked by Wall St. Rank hold AGN as of Q1 2016.

  • TD Securities (USA) held 89 shares of Allergan plc worth $24K as of Q1 2016.
  • TD Securities (USA) left its Allergan plc share count unchanged in Q1 2016.
  • Allergan plc made up 0.22% of TD Securities (USA)'s portfolio in Q1 2016, its #43 holding.
  • TD Securities (USA) first reported a position in Allergan plc in Q2 2013 and has held it in 12 quarters since.
  • TD Securities (USA)'s Allergan plc position peaked at $48.2M in Q2 2015.
  • 1,119 funds tracked by Wall St. Rank held Allergan plc as of Q1 2016.

Based on TD Securities (USA)'s 13F filing for Q1 2016, filed 27 Apr 2016.